The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes

Leukemia

Volumn 18, Issue 4, 2004, Pages 771-776

  Zambello, R ^a   Cabrelle, A ^a   Trentin, L ^a   Agostini, C ^a   Semenzato, G ^a   Viola, A ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Granular lymphocytes; Lymphoproliferative disease of granular lymphocytes; Rafts

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CHOLESTEROL; GAMMA INTERFERON; GLYCOSPHINGOLIPID; METHOTREXATE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL MEMBRANE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LARGE GRANULAR LYMPHOCYTE; LIPOGENESIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 16544395260     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403292     Document Type: Article

References (32)

1. Loughran Jr TP. Clonal diseases of large granular lymphocytes. Blood 1993; 82: 1-14.
2. Semenzato G, Pandolfi F, Chisesi T, De Rossi G, Pizzolo G, Zambello R et al. The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 1987; 60: 2971-2978.
3. Zambello R, Semenzato G. Large granular lymphocytosis. Haematologica 1998; 83: 936-942.
4. Lamy T, Loughran Jr TP. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13: 230-240.
5. Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, Perin A et al. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997; 89: 201-211.
6. Zambello R, Trentin L, Facco M, Cerutti A, Sancetta R, Milani A et al. Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes. Cancer Res 1995; 55: 6140-6145.
7. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran Jr TP. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3+ large granular lymphocyte leukemia. Blood 1998; 92: 4771-4777.
8. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F et al. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989; 84: 51-55.
9. Loughran Jr TP, Hadlock KG, Yang Q, Perzova R, Zambello R, Semenzato G et al. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes. Blood 1997; 90: 1977-1981.
10. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572.
11. Holowka D, Baird B. Antigen-mediated IgE receptor aggregation and signaling: a window on cell surface structure and dynamics. Annu Rev Biophys Biomol Struct 1996; 25: 79-112.
12. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14: 111-136.
13. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31-39.
14. Cinek T, Horejsi V. The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J Immunol 1992; 149: 2262-2270.
15. Zhang W, Trible RP, Samelson LE. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 1998; 9: 239-246.
16. Resh MD. Myristylation and palmitylation of Src family members: the fats of the matter. Cell 1994; 76: 411-413.
17. Stefanova J, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991; 254: 1016-1019.
18. Tuosto L, Parolini I, Schroder S, Sargiacomo M, Lanzavecchia A, Viola A. Organization of plasma membrane functional rafts upon T cell activation. Eur J Immunol 2001; 31: 345-349.
19. Viola A. The amplification of TCR signaling by membrane dynamic microdomains. Trends Immunol 2001; 22: 322-327.
20. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran Jr TP. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997; 86: 256-260.
21. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 1999; 283: 680-682.
22. Bachmann MF, Gallimore A, Linkert S, Cerundolo V, Lanzavecchia A, Kopf M et al. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J Exp Med 1999; 189: 1521-1530.
23. Pistoia V, Prasthofer EF, Tilden AB, Barton JC, Ferrarini M, Grossi CE et al. Large granular lymphocytes from patients with expanded LGL populations acquire cytotoxic functions and release lymphokines upon in vitro activation. Blood 1986; 68: 1095-1100.
24. Martin M, Schneider H, Azouz A, Rudd CE. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001; 194: 1675-1681.
25. Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA et al. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J 1998; 17: 5334-5348.
26. Janes PW, Ley SC, Magee AJ. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999; 147: 447-461.
27. Kasten-Sportes C, Zaknoen S, Steis RG, Chan WC, Winton EF, Waldmann TA. T cell receptor gene rearrangement in T-cell large granular leukocyte leukemia: preferential Vα but diverse Jα usage in one of five patients. Blood 1994; 83: 767-775.
28. Bigouret V, Hoffmann T, Arlettaz L, Villard J, Colonna M, Ticheli A et al. Monoclonal T cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94-NKG2C/E and NKD2D killer cell receptors. Blood 2003; 101: 3198-3204.
29. Zambello R, Falco M, Della Chiesa M, Trentin L, Carollo D, Castriconi R et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL). Blood 2003; 102: 1797-1805.
30. Pietra G, Romagnani C, Falco M, Vitale M, Castriconi R, Pende D et al. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Eur J Immuno 2001; 31: 3687-3693.
31. Romagnani C, Pietra G, Falco M, Millo E, Mazzarino P, Biassoni R et al. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci USA 2002; 99: 11328-11333.
32. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 2003; 24: 136-143.